Loading...

Patient Starts And Capacity Expansion Will Achieve Breakeven

Published
08 Apr 25
Updated
01 May 25
AnalystConsensusTarget's Fair Value
US$8.00
37.9% undervalued intrinsic discount
01 May
US$4.97
Loading
1Y
-72.5%
7D
-0.4%

Author's Valuation

US$8.0

37.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 24%

AnalystConsensusTarget has decreased profit margin from 19.3% to 17.3% and increased future PE multiple from 1.3x to 1.5x.